NEW YORK, Sept. 8 (GenomeWeb News) - Cepheid said today that it has received an order for 16 of its Smart Cycler II starter systems from the FDA for general use in food safety testing.

Financial terms of the deal were not disclosed.

Sunnyvale, Calif.-based Cepheid said roughly 60 percent of state public health institutions use Smart Cycler systems for pathogen detection.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.